SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-015276
Filing Date
2020-02-11
Accepted
2020-02-11 07:00:12
Documents
3
Period of Report
2020-02-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm207425d1_8k.htm 8-K 17254
2 EXHIBIT 99.1 tm207425d1_ex99-1.htm EX-99.1 13247
3 GRAPHIC image_001.jpg GRAPHIC 13641
  Complete submission text file 0001104659-20-015276.txt   50804
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 20593845
SIC: 2834 Pharmaceutical Preparations